Sign Out
Tabulated list of adverse reactions: The following table of listed adverse reactions is derived from clinical trials and post-marketing data associated with granisetron and other 5-HT3 antagonists.
The frequencies used in the table as follows are: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000). (See table.)
Click on icon to see table/diagram/imageDescription of selected adverse reactions: As for other 5-HT3 antagonists, ECG changes including QT prolongation have been reported with granisetron (see Precautions and Interactions).
View ADR Reporting Link
